Riskpilot
← Back to search
Sign in
Get full access
Svedala Optik AB
AB
Active
Org 5592968985
Hantverkaregatan 8, 233 32
Svedala
Retail sale of medical and orthopaedic goods
· NACE 4774
Est. 2021
1-4 employees
Watchlist
Share
Sweden
/
Companies
/
Retail sale of medical and orthopaedic goods
/
Svedala Optik AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
1M
1M
2M
2M
0M
2021
1M
2022
2M
2023
2M
2024
2M
2025
EBITDA
SEK millions
0M
0M
1M
1M
1M
0M
2021
0M
2022
0M
2023
0M
2024
0M
2025
Income statement
SEK thousands
Item
2021
2022
2023
2024
2025
Revenue
0
1 487
2 056
2 082
2 091
Staff expenses
—
−506
−780
−904
−1 069
EBITDA
—
−0
31
46
−78
Depreciation & amort.
−0
−10
−31
−35
−37
EBIT
0
−11
0
11
−115
Net financials
—
0
0
0
−0
Profit before tax
0
−11
0
11
−115
Tax
−0
—
—
—
—
Net profit
0
−11
0
11
−115
Balance sheet
SEK thousands
Item
2021
2022
2023
2024
2025
Total assets
25
523
535
583
559
Equity
25
14
14
25
20
Long-term debt
0
465
442
442
332
Short-term debt
0
43
79
116
207
Total debt
—
508
521
557
539
Financial ratios
5-year trend
EBITDA margin
-3.7%
This company
15.8%
Market median
-123% vs market
2021
2025
Equity ratio
3.6%
This company
38.2%
Market median
-91% vs market
2021
2025
Return on equity
-574.8%
This company
18.4%
Market median
-3224% vs market
2021
2025
Net profit margin
-5.5%
This company
8.1%
Market median
-168% vs market
2021
2025
Asset turnover
3.74×
This company
1.12×
Market median
+234% vs market
2021
2025
Debt / equity
26.92×
This company
0.62×
Market median
-4242% vs market
2021
2025
Annual reports & filings
Annual report 2025
Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
